Analyst Price Targets — CMPGY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 10:05 am | — | Compass Point | $15.00 | $31.73 | StreetInsider | Compass Inc. (COMP) PT Raised to $15 at BTIGMember Login |
| July 9, 2026 11:32 am | — | Compass Point | $40.00 | $32.25 | StreetInsider | Galaxy Digital (GLXY) PT Lowered to $40 at Compass PointMember Login |
| June 15, 2026 10:56 am | Michael Donovan | Compass Point | $90.00 | $34.22 | StreetInsider | Compass Point Reiterates Buy Rating on SharonAI Holdings Inc (SHAZ) |
| May 26, 2026 11:33 am | Michael Donovan | Compass Point | $50.00 | $31.29 | StreetInsider | WhiteFiber Inc (WYFI) PT Raised to $50 at Compass Point |
| February 9, 2026 2:26 pm | Stephen Ju | UBS | $17.00 | $28.38 | StreetInsider | Compass Inc. (COMP) PT Raised to $17 at UBS: 'improving momentum into year-end' |
| December 10, 2024 1:18 pm | David Rochester | Compass Point | $83.00 | $34.56 | TheFly | Wells Fargo price target raised to $83 from $60 at Compass Point |
| December 10, 2024 1:17 pm | David Rochester | Compass Point | $77.00 | $34.56 | TheFly | Synchrony price target raised to $77 from $60 at Compass Point |
| December 10, 2024 1:15 pm | David Rochester | Compass Point | $95.00 | $34.56 | TheFly | Prosperity Bancshares price target raised to $95 from $80 at Compass Point |
Latest News for CMPGY
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the second quarter and first half ended June 30, 2026, on August 5, 2026. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on August 5,…
CMPS leads regulated psilocybin with two successful Phase 3 trials and a rolling FDA submission, giving COMP360 a valuable head start in treatment-resistant depression. The core case rests on vast unmet need in depression, while encouraging PTSD data and other possible uses provide meaningful long-term upside beyond the first indication. Lilly's move for Atai validates the field and raises the competitive bar, but…
WESTPORT, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that it plans to report financial results for the second quarter ended June 30, 2026 on Monday, August 10, 2026 after market close. The Company has scheduled a conference call at 5:00 p.m. ET on August 10, 2026 to…
Compass Group PLC (CMPGY) Q3 2026 Sales/Trading Call Transcript
Compass Group LON: CPG reported another strong quarter in its third-quarter trading update, with Group Chief Executive Officer Dominic Blakemore saying the company delivered organic revenue growth of more than 7% and maintained client retention at 96%.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CMPGY.
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.